{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:51Z","timestamp":1793407851171,"version":"4.5.0"},"reference-count":23,"publisher":"American Association for Cancer Research (AACR)","issue":"4","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["A1007291"],"award-info":[{"award-number":["A1007291"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX005699"],"award-info":[{"award-number":["BX005699"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001238","name":"Merck Company Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C10674\/A27140"],"award-info":[{"award-number":["C10674\/A27140"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA196845"],"award-info":[{"award-number":["R01CA196845"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031234","name":"Michigan Medicine, University of Michigan","doi-asserted-by":"publisher","award":["AG024824"],"award-info":[{"award-number":["AG024824"]}],"id":[{"id":"10.13039\/100031234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Sporadic colorectal cancer remains a significant driver of worldwide morbidity and mortality. Environmental factors associated with colorectal cancer are increasingly well-described and now include generalized colonic dysbiosis and individual enteric bacteria. Clostridioides difficile is one such species, with recent mouse model work suggesting prolonged exposure to C. difficile toxin B is conducive to colonic tumorigenesis. However, there is a dearth of real-world human evidence linking C. difficile exposure and colorectal cancer. Herein, we analyzed a multicenter, longitudinal, electronic health record\u2013based dataset to test the association between C. difficile test positivity and the risk of incident colorectal cancer utilizing unadjusted and multivariable (controlled for clinical conditions independently associated with colorectal cancer development) Cox proportional hazard modeling to compare C. difficile exposed and nonexposed cohorts. We found that individuals who tested recurrently positive for C. difficile had a significantly increased risk of incident colorectal cancer [adjusted HR (aHR) 2.05 (95% confidence interval, 1.27\u20133.29)] compared with those who tested positive only once [aHR 0.70 (0.45\u20131.10)] or never. Furthermore, we found potential trends that the effect of C. difficile test positivity on the risk of incident colorectal cancer was stronger amongst females compared with males. These findings help translate emerging mouse model work on C. difficile\u2013influenced colorectal tumorigenesis and lay groundwork for more substantial human investigations into this connection. These findings also may begin to help guide the personalized deployment of novel fecal microbiota\u2013based therapies designed to interrupt the life cycle of C. difficile within the gut of human hosts and, potentially, prevent long-term health sequelae of chronic C. difficile infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>These findings help translate emerging mouse model work on C. difficile\u2013influenced colorectal tumorigenesis and lay groundwork for more substantial human investigations into this connection. These findings also may begin to help guide the personalized deployment of novel fecal microbiota\u2013based therapies designed to interrupt the life cycle of C. difficile within the gut of human hosts and, potentially, prevent long-term health sequelae of chronic C. difficile infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0606","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:28:52Z","timestamp":1775154532000},"page":"821-831","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between\n                    <i>Clostridioides difficile<\/i>\n                    Test Positivity and Colorectal Cancer Incidence in a Multisite Hospital-Based Retrospective Cohort Analysis"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-7232","authenticated-orcid":false,"given":"Samara","family":"Rifkin","sequence":"first","affiliation":[{"name":"1Division of Gastroenterology\/Hepatology, University of Michigan Medicine, Ann Arbor, Michigan."},{"name":"2Division of Gastroenterology, John D. Dingell VA Medical Center, Wayne State University School of Medicine, Detroit, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0340-4131","authenticated-orcid":false,"given":"Sean M.","family":"Anderson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037zgn354","id-type":"ROR","asserted-by":"publisher"}],"name":"Johns Hopkins Medicine 3 Division of Infectious Diseases, , Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8216-2145","authenticated-orcid":false,"given":"Xingyu","family":"Chen","sequence":"additional","affiliation":[{"name":"4Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-398X","authenticated-orcid":false,"given":"Kelly","family":"Gebo","sequence":"additional","affiliation":[{"name":"4Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-5289","authenticated-orcid":false,"given":"Eili","family":"Klein","sequence":"additional","affiliation":[{"name":"5Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-1267","authenticated-orcid":false,"given":"Nicholas O.","family":"Markham","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-8560","authenticated-orcid":false,"given":"Matthew","family":"Robinson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037zgn354","id-type":"ROR","asserted-by":"publisher"}],"name":"Johns Hopkins Medicine 3 Division of Infectious Diseases, , Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9213-7850","authenticated-orcid":false,"given":"Krishna","family":"Rao","sequence":"additional","affiliation":[{"name":"7Division of Infectious Diseases, University of Michigan Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-1661","authenticated-orcid":false,"given":"Cynthia L.","family":"Sears","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037zgn354","id-type":"ROR","asserted-by":"publisher"}],"name":"Johns Hopkins Medicine 3 Division of Infectious Diseases, , Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"2026041400420474000_bib1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Lin","year":"2021","journal-title":"JAMA"},{"key":"2026041400420474000_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026041400420474000_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41579-023-00973-4","article-title":"The microbial landscape of colorectal cancer","volume":"22","author":"White","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"2026041400420474000_bib4","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1136\/gutjnl-2019-318593","article-title":"Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989\u20132012: a matched case-control study","volume":"68","author":"Zhang","year":"2019","journal-title":"Gut"},{"key":"2026041400420474000_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djab126","article-title":"Antibiotic use impacts colorectal cancer: a double-edged sword by tumor location?","volume":"114","author":"Zhang","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"2026041400420474000_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jnci\/djab125","article-title":"Antibiotics use and subsequent risk of colorectal cancer: a Swedish nationwide population-based study","volume":"114","author":"Lu","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"2026041400420474000_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41522-017-0043-0","article-title":"High-resolution profiling of the gut microbiome reveals the extent of Clostridium difficile burden","volume":"3","author":"Daquigan","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2026041400420474000_bib8","doi-asserted-by":"crossref","first-page":"ofx018","DOI":"10.1093\/ofid\/ofx018","article-title":"Community environmental contamination of toxigenic Clostridium difficile","volume":"4","author":"Alam","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2026041400420474000_bib9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"key":"2026041400420474000_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12879-021-06147-y","article-title":"Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI","volume":"21","author":"Finn","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2026041400420474000_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.14740\/jocmr4919","article-title":"Colon cancer risk following intestinal Clostridioides difficile infection: a longitudinal cohort study","volume":"15","author":"Geier","year":"2023","journal-title":"J Clin Med Res"},{"key":"2026041400420474000_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.14740\/wjon1802","article-title":"Incidence of colorectal cancer after intestinal infection due to Clostridioides difficile","volume":"15","author":"Patel","year":"2024","journal-title":"World J Oncol"},{"key":"2026041400420474000_bib13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/2159-8290.CD-21-1273","article-title":"Human colon cancer\u2013derived Clostridioides difficile strains drive colonic tumorigenesis in mice","volume":"12","author":"Drewes","year":"2022","journal-title":"Cancer Discov"},{"key":"2026041400420474000_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.anaerobe.2017.08.012","article-title":"Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection","volume":"48","author":"G\u00f3mez","year":"2017","journal-title":"Anaerobe"},{"key":"2026041400420474000_bib15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41467-020-20746-4","article-title":"Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota","volume":"12","author":"Fletcher","year":"2021","journal-title":"Nat Commun"},{"key":"2026041400420474000_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/cid\/ciy415","article-title":"Comparison of Clostridioides difficile stool toxin concentrations in adults with symptomatic infection and asymptomatic carriage using an ultrasensitive quantitative immunoassay","volume":"68","author":"Pollock","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026041400420474000_bib17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1099\/mic.0.046243-0","article-title":"Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile","volume":"157","author":"Vohra","year":"2011","journal-title":"Microbiology (Reading)"},{"key":"2026041400420474000_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/M16-2733","article-title":"Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study","volume":"167","author":"Ma","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026041400420474000_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40121-024-00919-0","article-title":"A systematic literature review on risk factors for and timing of Clostridioides difficile infection in the United States","volume":"13","author":"Eeuwijk","year":"2024","journal-title":"Infect Dis Ther"},{"key":"2026041400420474000_bib20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/infdis\/jiad008","article-title":"Genistein inhibits Clostridioides difficile infection via estrogen receptors and lysine-deficient protein kinase 1","volume":"227","author":"Xie","year":"2023","journal-title":"J Infect Dis"},{"key":"2026041400420474000_bib21","doi-asserted-by":"crossref","first-page":"17562848241253089","DOI":"10.1177\/17562848241253089","article-title":"Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone","volume":"17","author":"DuPont","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"key":"2026041400420474000_bib22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori therapy for the prevention of metachronous gastric cancer","volume":"378","author":"Choi","year":"2018","journal-title":"N Engl J Med"},{"key":"2026041400420474000_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.1997.v112.agast970594","article-title":"Colorectal cancer screening: clinical guidelines and rationale","volume":"112","author":"Winawer","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0606\/3763174\/crc-25-0606.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/4\/821\/3769712\/crc-25-0606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/4\/821\/3769712\/crc-25-0606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:42:23Z","timestamp":1776141743000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/4\/821\/783548\/Association-between-Clostridioides-difficile-Test"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0606","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32729644","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729632","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729641","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729629","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729638","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729647","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729635","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8545258","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}